Suppr超能文献

核苷和核苷酸类药物的细胞与组织特异性代谢:案例研究及其对精准医学的启示

Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision Medicine.

作者信息

To Elaine E

机构信息

Gilead Sciences, Inc., Foster City, California, USA

出版信息

Drug Metab Dispos. 2023 Mar;51(3):360-368. doi: 10.1124/dmd.122.000856. Epub 2022 Nov 29.

Abstract

Many clinically used antiviral drugs are nucleoside or nucleotide analog drugs, which have a unique mechanism of action that requires intracellular phosphorylation. This dependence on intracellular activation presents novel challenges for the discovery and development of nucleoside/nucleotide analog drugs. Contrary to many small molecule drug development programs that rely on plasma pharmacokinetics and systemic exposures, the precise mechanisms that result in efficacious intracellular nucleoside triphosphate concentrations must be understood in the process of nucleoside/nucleotide drug development. The importance is highlighted here, using the following as case studies: the herpes treatment acyclovir, the cytomegalovirus therapy ganciclovir, and human immunodeficiency virus (HIV) treatments based on tenofovir, which are also in use for HIV prophylaxis. For each drug, the specificity of metabolism that results in its activation in different cells or tissues is discussed, and the implications explored. Acyclovir's dependence on a viral enzyme for activation provides selective pressure for resistance mutations. Ganciclovir is also dependent on a viral enzyme for activation, and suicide gene therapy capitalizes on that for a novel oncology treatment. The tissue of most relevance for tenofovir activation depends on its use as treatment or as prophylaxis, and the pharmacogenomics and drug-drug interactions in those tissues must be considered. Finally, differential metabolism of different tenofovir prodrugs and its effects on toxicity risk are explored. Taken together, these examples highlight the importance of understanding tissue specific metabolism for optimal use of nucleoside/nucleotide drugs in the clinic. SIGNIFICANCE STATEMENT: Nucleoside and nucleotide analogue drugs are cornerstones in current antiviral therapy and prevention efforts that require intracellular phosphorylation for activity. Understanding their cell and tissue specific metabolism enables their rational, precision use for maximum efficacy.

摘要

许多临床使用的抗病毒药物是核苷或核苷酸类似物药物,它们具有独特的作用机制,需要细胞内磷酸化。这种对细胞内激活的依赖性给核苷/核苷酸类似物药物的发现和开发带来了新的挑战。与许多依赖血浆药代动力学和全身暴露的小分子药物开发项目不同,在核苷/核苷酸药物开发过程中,必须了解导致有效细胞内核苷三磷酸浓度的精确机制。这里以以下药物为例突出其重要性:用于治疗疱疹的阿昔洛韦、用于治疗巨细胞病毒的更昔洛韦,以及用于治疗人类免疫缺陷病毒(HIV)且也用于HIV预防的替诺福韦。对于每种药物,讨论了导致其在不同细胞或组织中激活的代谢特异性,并探讨了其影响。阿昔洛韦对病毒酶激活的依赖性为耐药突变提供了选择压力。更昔洛韦也依赖病毒酶激活,自杀基因疗法利用这一点进行新型肿瘤治疗。与替诺福韦激活最相关的组织取决于其作为治疗药物还是预防药物的用途,并且必须考虑这些组织中的药物基因组学和药物相互作用。最后,探讨了不同替诺福韦前药的差异代谢及其对毒性风险的影响。综上所述,这些例子突出了了解组织特异性代谢对于在临床上最佳使用核苷/核苷酸药物的重要性。意义声明:核苷和核苷酸类似物药物是当前抗病毒治疗和预防工作的基石,其活性需要细胞内磷酸化。了解它们的细胞和组织特异性代谢能够合理、精准地使用它们以实现最大疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验